Xeris Biopharma Holdings, Inc.
Hedge Funds Holdings
Last updated:
Xeris Biopharma Holdings, Inc.‘s stocks are currently a part of 100 hedge funds’ portfolios, which represents 63.87% of the total amount of its stocks outstanding. This makes up a total of 50.47M shares of Xeris Biopharma Holdings, Inc.. Compared to the previous quarter, the number grew by 23.05% or 9.45M shares more. As for the holding position changes, 29% (29) of current hedge fund investors increased the number of shares held, 26% (26) of current holders sold a part of the shares held, and 14% (14) closed the holdings completely. 28 hedge funds are new holders of Xeris Biopharma Holdings, Inc. stock in Q1 2022, it is 28% of total holders.
Hedge funds holding Xeris Biopharma Holdings (Q2 2018 – Q1 2022)
| Q2 2018 | 31 |
|---|---|
| Q3 2018 | 36 |
| Q4 2018 | 35 |
| Q1 2019 | 49 |
| Q2 2019 | 48 |
| Q3 2019 | 53 |
| Q4 2019 | 54 |
| Q1 2020 | 65 |
| Q2 2020 | 83 |
| Q3 2020 | 85 |
| Q4 2020 | 92 |
| Q1 2021 | 98 |
| Q2 2021 | 89 |
| Q3 2021 | 66 |
| Q4 2021 | 88 |
| Q1 2022 | 100 |
Hedge funds changes in Xeris Biopharma Holdings positions (Q2 2018 – Q1 2022)
| Q2 2018 | 31 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q3 2018 | 20 | 10 | 2 | 15 | -11 |
| Q4 2018 | 2 | 17 | 9 | 3 | 4 |
| Q1 2019 | 18 | 23 | 2 | 4 | 2 |
| Q2 2019 | 11 | 21 | 8 | 10 | -2 |
| Q3 2019 | 7 | 26 | 10 | 2 | 8 |
| Q4 2019 | 9 | 23 | 10 | 8 | 4 |
| Q1 2020 | 21 | 24 | 13 | 10 | -3 |
| Q2 2020 | 28 | 35 | 14 | 10 | -4 |
| Q3 2020 | 26 | 27 | 21 | 24 | -13 |
| Q4 2020 | 20 | 36 | 24 | 13 | -1 |
| Q1 2021 | 18 | 39 | 25 | 12 | 4 |
| Q2 2021 | 23 | 21 | 35 | 32 | -22 |
| Q3 2021 | 8 | 23 | 23 | 31 | -19 |
| Q4 2021 | 86 | 1 | 0 | 64 | -63 |
| Q1 2022 | 28 | 29 | 26 | 14 | 3 |
Hedge funds changes in Xeris Biopharma Holdings stock options (Q2 2018 – Q1 2022)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 9,000 | 3,000 |
| Q4 2019 | 194,000 | 2,000 |
| Q1 2020 | 22,000 | 23,000 |
| Q2 2020 | 0 | 685,000 |
| Q3 2020 | 13,436,000 | 457,000 |
| Q4 2020 | 11,292,000 | 2,596,000 |
| Q1 2021 | 10,308,000 | 1,348,000 |
| Q2 2021 | 8,896,000 | 2,393,000 |
| Q3 2021 | 5,305,000 | 1,239,000 |
| Q4 2021 | 6,722,000 | 1,920,000 |
| Q1 2022 | 4,230,000 | 320,000 |